ForCast Orthopedics
ForCast Orthopedics: Enhancing joint replacement outcomes with targeted treatments for orthopedic infections.
Founded
2017ForCast Orthopedics: Enhancing joint replacement outcomes with targeted treatments for orthopedic infections.
Founded with the mission to modernize the standard of care for periprosthetic joint infections (PJI), ForCast Orthopedics focuses on enhancing patient outcomes post-joint replacement. The company offers targeted antibiotic therapies specifically designed to treat PJI, aiming to improve the quality of life for the increasing number of joint replacement patients. Their innovative approach addresses a critical need in orthopedic care, providing specialized solutions that are both effective and patient-centric.
Notable figures affiliated with ForCast Orthopedics include leading orthopedic surgeons and medical researchers who contribute to the development and refinement of their treatments. The company has garnered attention from investors in the medical device and healthcare sectors, reflecting confidence in its potential impact. Key achievements include successful clinical trials demonstrating the efficacy of their targeted therapies. Overall, ForCast Orthopedics is making significant strides in transforming the treatment landscape for orthopedic infections, ultimately benefiting patients and healthcare providers alike.
Companies similar to ForCast Orthopedics include Osteal Therapeutics, Reselute, Cymedica Orthopedics and RevOrtho.
ForCast Orthopedics was founded in 2017.
ForCast Orthopedics' headquarters is located in Longmont, CO, US.
ForCast Orthopedics' most recent funding round was for $999.9k (USD) in September 2020.
As of Sep 11, 2020, ForCast Orthopedics has disclosed funding of $1.2M (USD). Undisclosed round amounts are excluded.
ForCast Orthopedics has 4 employees as of Feb 4, 2024.
RevOrtho
revortho.com
